The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...

After hours: February 3 at 4:46:18 PM EST Loading Chart for GLUE ...

Old-vine California Cabernet has never been in higher demand, and we just got a preview tasting of some of the state's newest bottlings ...